Epidural Spinal Electrodes

Products	Epidural Spinal Electrodes
Company	Ad-Tech Medical
Item	Epidural Spinal Electrodes
Features	2 or 3 platinum contacts Available in a wide range of product & connection configurations Soft and flexible body; some models with Tuohy needles, come with an introducing stylet; some with both Sterile; single-use only
Description	Ad-Techs Spinal Electrodes are intended for intraoperative monitoring of Evoked Potentials (EPs) of the descending pathway during spinal surgery. They are offered with 2 or 3 platinum contacts.
Info	Ad-Tech Medical Customer Service: (800) 776-1555 Web site: http://www.adtechmedical.com

TAG: Epidural Spinal Electrodes

Launcher Coronary Guide Catheter gives a dependable platform for optimal outcomes with absolute visualization and a proprietary design....

... Fast-Cath, Maximum, Maximum Xtra, and Maximum ... of standard and specialty hemostasis introducers ... as the premier hemostasis introducers for ... procedures including angiography, angioplasty, stenting, atherectomy, ...

St. Jude Medical's line of guiding introducers includes Swartz Series, SAFL, SEPT, CSTA, RAMP, and 2 piece steerable...

... Ultimum hemostasis introducers provide ... wire-to-dilator and dilator-to-sheath transitions, high ... thickness. A dual layer sheath ... flexibility, and works with an ...

Medicine Products:

Launcher Fast-Cath Duo Hemostasis Introducers Fast-Cath Guiding Introducers Ultimum Introducers

(Date:12/17/2009)... Samaritan Hospital is changing the way women manage their ... the Good Samaritan Hospital Women,s Center For Bladder & ... treat two common medical problems - lack of bladder ... or rectum (pelvic organ prolapse). Three out of four ... out of three may experience pelvic organ prolapse, but ...

(Date:12/17/2009)... Canadian teenagers are among the largest consumers of ... on young brains are worse than originally thought, according ... researcher from the Research Institute of the McGill University ... of Disease , suggests that daily consumption of cannabis ... an irreversible long-term effect on the brain. , "We ...

(Date:12/17/2009)... infections , , THURSDAY, Dec. 17 (HealthDay News) -- Some ... flu virus, and researchers say they,ve found a clue ... of the illness appears to be a molecule called ... off germs and disease. Researchers who analyzed levels of ... last summer found the highest levels in the blood ...

(Date:12/17/2009)... delivered during computed tomography examinations underscore the important role ... and protecting patients, according to the American Society of ... ... Albuquerque, NM (Vocus) December 16, 2009 -- Two ... examinations underscore the important role that competent, educated CT ...

(Date:12/17/2009)... Solutions ( www.CareTech.com ), an information technology (IT) and ... systems, was named Best in KLAS, Extensive IT ... Best in KLAS Awards: Software & Professional Services ... vendors in key market segments including EMRs, cardiology systems, ... overall performance score was 90.3 on a 100-point scale ...

Breaking Medicine News(10 mins):Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 2 Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 3 Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 2 Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 3 Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 4 Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 2 Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 3

[0] Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health [0] Cannabis and adolescence [0] Scientists Link Molecule to Severe Swine Flu [0] ASRT Supports Efforts to Minimize CT Radiation Dose [0] CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year

... Kotlus and Dr.,Charles Mok of Shelby Township ... new cosmetic treatments and also to share information about ... our medical spa are,information gatherers, but it can be ... on the internet regarding the cosmetic field.,There are literally ...

... PITTSBURGH, Feb. 19 Mylan Inc. (Nasdaq: MYL ) ... transition out of his role over the next several months. Borkowski ... place. Mylan,s Vice Chairman and CEO Robert J. Coury stated: "Not ... brought to Mylan over the last seven years, I want to ...

... 15%; Online Ad Revenue Increased 21%WebMD Achieves Record ... 1.3 Billion Quarterly Page ViewsNEW YORK, Feb. 19 ... ) today announced financial results for the three ... confirm WebMD,s market leadership in a challenging business ...

... SCOTTSDALE, Ariz., Feb. 19 Examination Management ... of the company to capitalize on their leadership position ... advantage of the significant growth opportunities in new markets. ... organized into three operating divisions: Insurance Services, Healthcare ...

... The Committee for Medicinal Products for Human Use ... Agency (EMEA), today adopted a positive opinion recommending ... for the treatment of postmenopausal osteoporosis in women ... investigational medicine, is in development by Wyeth Pharmaceuticals, ...

... For millions of Americans with cancer, the side ... be devastating. But new drug-delivery research based on ... provide much-needed relief, as well as more effective ... by Prof. Rimona Margalit of Tel Aviv University,s ...

Your Doctor Has a Blog Mylan Announces Transition of Chief Financial Officer WebMD Announces Fourth Quarter Financial Results EMSI Realigns Internal Divisions for More Effective Focus on Customers CONBRIZA Receives Positive CHMP Opinion for the Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture New 'bubble' targets only cancer cells

(Date:12/17/2009)... Decision Resources, one of the world,s ... and healthcare issues, finds that over 70 percent ... high need for diabetes drugs with novel mechanisms ... is a high need for additional DPP-IV inhibitors. ... excellent glucose lowering ability and physicians in particular ...

(Date:12/17/2009)... Dec. 17 Protalix BioTherapeutics, Inc. (NYSE-Amex: ... Sandra Lauterbach to Vice President, Sales and Commercial ... position, Ms. Lauterbach will be responsible for all ... taliglucerase alfa in accordance with the collaboration agreement ... as any other products that emerge from the ...

(Date:12/17/2009)... N.J., Dec. 17 BASF ... has approved the use of Aseptrol® S10 - ... industrial facilities, such as, schools, hospitals, government buildings, ... S10 - Tab is based on Chlorine dioxide ... delivers a broad spectrum disinfectant as stated ...

Breaking Medicine Technology:Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors 2 Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors 3 Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 2 Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 3 Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 4 BASF's Aseptrol(R) S10 - Tab Receives EPA Approval For H1N1 Sanitization Label 2 BASF's Aseptrol(R) S10 - Tab Receives EPA Approval For H1N1 Sanitization Label 3 Nations Oldest Taxpayer Group Criticizes Committee Vote for Baucus Health Bill Hidden Tax Increases 59401 1 Nations Oldest Taxpayer Group Criticizes Committee Vote for Baucus Health Bill Hidden Tax Increases 59401 2 Global Bioenergies is Setting Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Rene 14455 1 Global Bioenergies is Setting Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Rene 14455 2 Cepheid Schedules 2009 Third Quarter Financial Results Announcement and Webcast 14452 1 Cepheid Schedules 2009 Third Quarter Financial Results Announcement and Webcast 14452 2

[0] Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors [0] Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs [0] BASF's Aseptrol(R) S10 - Tab Receives EPA Approval For H1N1 Sanitization Label